Project Details
Description
Evaluation of predictive biomarkers and the host immune response to intrapleural administration of oncolytic Measles virus in a phase I clinical trial specifically for patients with mesothelioma
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/11 → 12/31/13 |
Funding
- MESOTHELIOMA APPLIED RESEARCH FOUNDATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.